Comparing Belbuca vs Subutex
Belbuca | Subutex |
|
---|
Belbuca (buprenorphine) | Subutex (buprenorphine) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Chronic Pain, Pain. Belbuca may also be used for purposes not listed in this medication guide. |
Prescription only
Subutex was a brand name of sublingual buprenorphine, but it has been discontinued. [Suboxone](https://www.drugs.com/suboxone.html), which contains buprenorphine and naloxone, may be used instead... View more |
||||||||
More about Belbuca (buprenorphine) | More about Subutex (buprenorphine) | ||||||||
Ratings & Reviews | |||||||||
Belbuca has an average rating of 4.5 out of 10 from a total of 247 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 51% reported a negative effect. |
Subutex has an average rating of 8.6 out of 10 from a total of 144 ratings on Drugs.com. 84% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||
Drug Class | |||||||||
None |
|||||||||
Side Effects | |||||||||
See also: Belbuca side effects in more detail. |
See also: Subutex side effects in more detail. |
||||||||
Generic Availability | |||||||||
Lower cost generic approved | |||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Belbuca prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Other buprenorphine brands include: Brixadi, Buprenex, Butrans, Sublocade | Other buprenorphine brands include: Belbuca, Brixadi, Buprenex, Butrans, Sublocade | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
48 hours |
48 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 692 drugs are known to interact with Belbuca:
|
A total of 692 drugs are known to interact with Subutex:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
October 23, 2015 |
October 08, 2002 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.